CIK 0001022899 · Non-accelerated filer<br>Smaller reporting company
Protagenic Therapeutics, Inc.new
Sign in to watch- Ticker
- PTIX
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061390025
- Phone
- (212) 994-8200
- Business address
- 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
- Former names
- Atrinsic, Inc., NEW MOTION, INC., MPLC, Inc., MILLBROOK PRESS INC
- DEF 14A Proxy Proxy Statement
- 8-K Event Auditor change
- 10-K/A Report 10-K/A
- 10-K Report Annual Report
- 8-K Event Bylaws or fiscal year change
- 8-K Event Bylaws or fiscal year change
- 8-K/A Event Material agreement · Acquisition or sale completed · Unregistered share sale · Change in control · Executive or director change · Bylaws or fiscal year change
- 8-K Event Auditor change · Bylaws or fiscal year change · Shareholder vote results
- DEF 14A Proxy Proxy Statement
- 8-K Event Other events
- 8-K/A Event Material agreement · Unregistered share sale
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Executive or director change
- 8-K Event Bylaws or fiscal year change
- 8-K Event Unregistered share sale
- 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Change in control · Executive or director change · Bylaws or fiscal year change · Shell status change
- 8-K Event New debt or obligation · Executive or director change
- 8-K Event Material agreement · New debt or obligation · Other events
- 8-K Event Material agreement · New debt or obligation
- 10-K Report Annual Report
Page 6 of 12 · 233 filings